Phathom Pharmaceuticals Q3 net income USD -13.9 million

PHAT•2026-10-29

Phathom Pharmaceuticals reported third-quarter net income of USD -13.9 million and revenue of USD 84.7 million, versus an IBES estimate of USD 84.9 million.

1. Quarterly results

Phathom Pharmaceuticals reported third-quarter revenue of USD 84.7 million, compared with the IBES estimate of USD 84.9 million. Net income was USD -13.9 million.

Phathom Pharmaceuticals Q3 net income USD -13.9 million

1. Quarterly results

Related News

aTyr Pharma's efzofitimod misses primary endpoint in Phase 3 pulmonary sarcoidosis trial

Coherus Oncology reports 89% confirmed response rate for tagmokitug combination in first-line esophageal cancer trial

U.S. home-sale prices fall 0.1% year over year, Redfin reports

Shimmick updates financial calendar

Cognex plans presentations at four investor conferences